- Home
- NWFL vs ALDX Comparison
NWFL vs ALDX Comparison
Compare NWFL & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWFL
- ALDX
- Stock Information
- Founded
- NWFL 1870
- ALDX 2004
- Country
- NWFL United States
- ALDX United States
- Employees
- NWFL N/A
- ALDX N/A
- Industry
- NWFL Major Banks
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- NWFL Finance
- ALDX Health Care
- Exchange
- NWFL Nasdaq
- ALDX Nasdaq
- Market Cap
- NWFL 228.7M
- ALDX 270.7M
- IPO Year
- NWFL 1998
- ALDX 2014
- Fundamental
- Price
- NWFL $24.62
- ALDX $5.17
- Analyst Decision
- NWFL Buy
- ALDX Strong Buy
- Analyst Count
- NWFL 3
- ALDX 2
- Target Price
- NWFL $28.50
- ALDX $9.50
- AVG Volume (30 Days)
- NWFL 25.8K
- ALDX 1.3M
- Earning Date
- NWFL 07-22-2025
- ALDX 08-04-2025
- Dividend Yield
- NWFL 5.04%
- ALDX N/A
- EPS Growth
- NWFL N/A
- ALDX N/A
- EPS
- NWFL 0.37
- ALDX N/A
- Revenue
- NWFL $53,958,000.00
- ALDX N/A
- Revenue This Year
- NWFL $79.89
- ALDX N/A
- Revenue Next Year
- NWFL $7.62
- ALDX N/A
- P/E Ratio
- NWFL $67.25
- ALDX N/A
- Revenue Growth
- NWFL N/A
- ALDX N/A
- 52 Week Low
- NWFL $21.25
- ALDX $1.14
- 52 Week High
- NWFL $34.50
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- NWFL 43.76
- ALDX 67.36
- Support Level
- NWFL $24.40
- ALDX $5.21
- Resistance Level
- NWFL $25.20
- ALDX $5.66
- Average True Range (ATR)
- NWFL 0.57
- ALDX 0.32
- MACD
- NWFL -0.08
- ALDX -0.01
- Stochastic Oscillator
- NWFL 31.82
- ALDX 68.40
About NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.